| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| Accelerate Resources Ltd | ASX | $6.12 m | 0.04 AUD | -2.50% |
| Acceleron Pharma Inc | NASDAQ | $9.73 billion | 159.84 USD | 3.50% |
| Acceleware Ltd | TSX-V | $31.74 m | 0.30 CAD | -3.23% |
| Accell Group NV | OTC | $1.32 billion | 49.20 USD | 4.66% |
| Accelrys Inc | NASDAQ | 0.00 | 0.00% | |
| Accent Group Ltd | ASX | $1.19 billion | 2.19 AUD | 4.78% |
| Accent Resources | ASX | $25.63 m | 0.06 AUD | 1.85% |
| Accenture | NYSE | $217.51 billion | 343.00 USD | 2.49% |
| Access Intelligence Group | AIM | £196.44 m | 154.00 GBX | 0.00% |
| Access Worldwide Communications, Inc. | OTC | $151.69 k | 0.00 USD | -2.38% |
| Accesso Technology Group PLC | AIM | £381.59 m | 925.00 GBX | 3.93% |
| Accident Exchange Group | Unlisted (UK) | 0.00 | 0.00% | |
| Acciona S.A. | OTC | $9.16 billion | 167.65 USD | -5.28% |
| Accloud PLC | Unlisted (UK) | 0.00 | 0.00% | |
| Accor SA Ltd. | OTC | $9.12 billion | 34.84 USD | 1.22% |
| Accord Financial | TSX | $71.47 m | 8.35 CAD | 0.60% |
| Accordia Golf | 0.00 | 0.00% | ||
| Accretive Health | NYSE | 0.00 | 0.00% | |
| Accrol Group Holdings PLC | AIM | £152.26 m | 47.75 GBX | -1.95% |
| Accsys Technologies | AIM | £322.57 m | 167.75 GBX | -1.03% |
| Accuray Inc | NASDAQ | $345.15 m | 3.80 USD | 6.44% |
| Ace Liberty & Stone PLC | AQSE | 0 | 85.00 GBX | -0.58% |
| ACE Limited | NYSE | 0.00 | 0.00% | |
| AcelRx Pharmaceuticals | NASDAQ | $121.56 m | 1.02 USD | -0.97% |
| AcenciA Debt Strategies | LSE | 0.00 | 0.00% | |
| Acer Energy | ASX | 0.00 | 0.00% | |
| Acer Therapeutics | Unlisted (US) | 0.00 | 0.00% | |
| Acerinox S.A. | OTC | $3.52 billion | 6.50 USD | 0.15% |
| Acerus Pharmaceuticals Corporation | TSX | $61.5 m | 0.04 CAD | 0.00% |
| Aceto Corporation | NASDAQ | $231.81 m | 7.28 USD | 3.85% |
| Achaogen | NASDAQ | 0.00 | 0.00% | |
| Achieve Life Sciences Inc | NASDAQ | $83.65 m | 8.85 USD | -0.67% |
| Achillion Pharmaceuticals, Inc. | NASDAQ | 0.00 | 0.00% | |
| ACI Worldwide Inc | NASDAQ | $3.69 billion | 31.42 USD | 1.39% |
| Ackroo | TSX-V | $17.32 m | 0.15 CAD | -3.23% |
| ACME Lithium Inc. | CSE | $42.76 m | 1.18 CAD | -5.60% |
| Acme Packet, Inc. | NASDAQ | 0.00 | 0.00% | |
| Acorda Therapeutics Inc | NASDAQ | $49.61 m | 4.46 USD | 2.29% |
| Acorn International, Inc. (ADR) | NYSE | 0.00 | 0.00% | |
| ACP CAPITAL | Unlisted (UK) | 0.00 | 0.00% |